A Study of Nivolumab In Combination With Cabozantinib in Patients With Non-Clear Cell Renal Cell Carcinoma

Clinical trial NCT03635892 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03635892
Sponsor: Memorial Sloan Kettering Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma Unclassified Renal Cell Carcinoma Papillary Renal Cell Carcinoma Fumarate Hydratase Deficient Renal Cell Carcinoma Succinate Dehydrogenase Deficient Renal Cell Carcinoma Collecting Duct Renal Cell Carcinoma Chromophobe Renal Cell Carcinoma

Start date: 2018-08-13
Primary completion: 2026-08-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.